• Afon Technologies, based in the UK, is developing a continuous non-invasive glucose monitor.
• The device sits on the skin and uses Bluetooth to communicate with an app.
• It neatly can be worn with a watch, and provides a continuous log of data.
• Afon recently posted to its Twitter, promising news of an in-house study against ‘minimally invasive device’: https://twitter.com/AfonLtd/status/1509108689738862596
• The device is not yet through FDA clearance, but is where the future is heading for wearables and biometric measurements.

See more below:

Afon Technology, the future of blood glucose monitoring to benefit diabetics